Barclays’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-9,892
| Closed | -$1.17M | – | 4340 |
|
|
2021
Q1 | $1.17M | Buy |
9,892
+9,655
| +4,074% | +$1.14M | ﹤0.01% | 2214 |
|
|
2020
Q4 | $28K | Sell |
237
-14,251
| -98% | -$1.68M | ﹤0.01% | 3335 |
|
|
2020
Q3 | $1.61M | Buy |
14,488
+3,871
| +36% | +$430K | ﹤0.01% | 1629 |
|
|
2020
Q2 | $1.09M | Buy |
10,617
+10,594
| +46,061% | +$1.08M | ﹤0.01% | 1872 |
|
|
2020
Q1 | $2K | Sell |
23
-8,107
| -100% | -$705K | ﹤0.01% | 3601 |
|
|
2019
Q4 | $947K | Sell |
8,130
-691
| -8% | -$80.5K | ﹤0.01% | 2334 |
|
|
2019
Q3 | $1.01M | Sell |
8,821
-881
| -9% | -$101K | ﹤0.01% | 2251 |
|
|
2019
Q2 | $924K | Buy |
9,702
+8,462
| +682% | +$806K | ﹤0.01% | 2386 |
|
|
2019
Q1 | $113K | Sell |
1,240
-3,213
| -72% | -$293K | ﹤0.01% | 3284 |
|
|
2018
Q4 | $339K | Buy |
4,453
+2,451
| +122% | +$187K | ﹤0.01% | 2478 |
|
|
2018
Q3 | $159K | Sell |
2,002
-145
| -7% | -$11.5K | ﹤0.01% | 3183 |
|
|
2018
Q2 | $213K | Sell |
2,147
-591
| -22% | -$58.6K | ﹤0.01% | 2722 |
|
|
2018
Q1 | $222K | Buy |
2,738
+493
| +22% | +$40K | ﹤0.01% | 2791 |
|
|
2017
Q4 | $176K | Sell |
2,245
-1,567
| -41% | -$123K | ﹤0.01% | 2715 |
|
|
2017
Q3 | $352K | Buy |
3,812
+3,444
| +936% | +$318K | ﹤0.01% | 2107 |
|
|
2017
Q2 | $42K | Buy |
368
+205
| +126% | +$23.4K | ﹤0.01% | 3078 |
|
|
2017
Q1 | $17K | Sell |
163
-667
| -80% | -$69.6K | ﹤0.01% | 3415 |
|
|
2016
Q4 | $89K | Buy |
+830
| New | +$89K | ﹤0.01% | 2653 |
|
|
2016
Q3 | – | Sell |
-417
| Closed | -$44K | – | 4177 |
|
|
2016
Q2 | $44K | Buy |
417
+224
| +116% | +$23.6K | ﹤0.01% | 2611 |
|
|
2016
Q1 | $22K | Sell |
193
-282
| -59% | -$32.1K | ﹤0.01% | 2762 |
|
|
2015
Q4 | $67K | Buy |
+475
| New | +$67K | ﹤0.01% | 2411 |
|